SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation of Class Action Lawsuit and Upcoming Deadline – IMVT; HSACU; HSAC; and HSACW
- Thursday, April 1, 2021, 3:30
- Business
- Add a comment
NEW YORK, April 1, 2021 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation (“HSAC”, “Immunovant”, or the “Company”) (NASDAQ: IMVT; HSACU; HSAC; and HSACW) and certain of its officers….
About the Author
adminasapcorp has written 41268 stories on this site.